BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20975575)

  • 21. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model.
    de Lacorte Singulani J; Scorzoni L; de Paula E Silva AC; Fusco-Almeida AM; Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Sep; 48(3):292-7. PubMed ID: 27444116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Paracoccidioidomycosis in pediatric patients: a description of 4 cases].
    Taicz M; Rosanova MT; Bes D; Lisdero ML; Iglesias V; Santos P; Berberian G
    Rev Iberoam Micol; 2014; 31(2):141-4. PubMed ID: 23792123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracoccidioidomycosis in a Spanish missionary.
    Ramírez-Olivencia G; Ramírez-Rubio O; González PR; Herrero MD; Puente SP
    J Travel Med; 2010; 17(2):139-40. PubMed ID: 20412183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imported paracoccidioidomycosis in Spain].
    Botas-Velasco M; Jover-Díaz F; Ortiz de la Tabla-Duccase V; Martínez-García C
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):259-60. PubMed ID: 19729228
    [No Abstract]   [Full Text] [Related]  

  • 25. Important aspects of oral paracoccidioidomycosis--a literature review.
    Abreu e Silva MÀ; Salum FG; Figueiredo MA; Cherubini K
    Mycoses; 2013 May; 56(3):189-99. PubMed ID: 23088400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional genome of the human pathogenic fungus Paracoccidioides brasiliensis.
    Felipe MS; Torres FA; Maranhão AQ; Silva-Pereira I; Poças-Fonseca MJ; Campos EG; Moraes LM; Arraes FB; Carvalho MJ; Andrade RV; Nicola AM; Teixeira MM; Jesuíno RS; Pereira M; Soares CM; Brígido MM
    FEMS Immunol Med Microbiol; 2005 Sep; 45(3):369-81. PubMed ID: 16061364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in paracoccidioidomycosis.
    Ameen M; Talhari C; Talhari S
    Clin Exp Dermatol; 2010 Aug; 35(6):576-80. PubMed ID: 19874328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brazilian Red Propolis shows antifungal and immunomodulatory activities against Paracoccidioides brasiliensis.
    Santos LA; Rosalen PL; Dias NA; Grisolia JC; Nascimento Gomes BJ; Blosfeld-Lopes L; Ikegaki M; Alencar SM; Burger E
    J Ethnopharmacol; 2021 Sep; 277():114181. PubMed ID: 33991639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into a complex fungal pathogen: the case of Paracoccidioides spp.
    Gonzalez A; Hernandez O
    Yeast; 2016 Apr; 33(4):113-28. PubMed ID: 26683539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of the association of dodecyl gallate with nanostructured lipid system as a treatment for paracoccidioidomycosis: In vitro and in vivo efficacy and toxicity.
    Singulani JL; Scorzoni L; Lourencetti NMS; Oliveira LR; Conçolaro RS; da Silva PB; Nazaré AC; Polaquini CR; Victorelli FD; Chorilli M; Regasini LO; Fusco Almeida AM; Mendes Giannini MJS
    Int J Pharm; 2018 Aug; 547(1-2):630-636. PubMed ID: 29883792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe forms of paracoccidioidomycosis: is there a role for corticosteroids?
    Benard G; Campos AF; Netto LC; Gonçalves LG; Machado LR; Mimicos EV; França FO; Gryschek RC
    Med Mycol; 2012 Aug; 50(6):641-8. PubMed ID: 22309459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paracoccidioidomycosis of the mouth: an emerging deep mycosis.
    Almeida OP; Jorge Junior J; Scully C
    Crit Rev Oral Biol Med; 2003; 14(4):268-74. PubMed ID: 12907695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The case for paracoccidioidomycosis to be accepted as a neglected tropical (fungal) disease.
    Griffiths J; Lopes Colombo A; Denning DW
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007195. PubMed ID: 31095569
    [No Abstract]   [Full Text] [Related]  

  • 34. Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues.
    Bocca AL; Amaral AC; Teixeira MM; Sato PK; Shikanai-Yasuda MA; Soares Felipe MS
    Future Microbiol; 2013 Sep; 8(9):1177-91. PubMed ID: 24020744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of laryngeal paracoccidioidomycosis masquerading as chronic obstructive lung disease.
    Tristano AG; Díaz L
    South Med J; 2007 Jul; 100(7):709-11. PubMed ID: 17639751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis.
    Dietze R; Fowler VG; Steiner TS; Pecanha PM; Corey GR
    Am J Trop Med Hyg; 1999 May; 60(5):837-9. PubMed ID: 10344661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imported acute and isolated glottic paracoccidioidomycosis.
    Laccourreye O; Mirghani H; Brasnu D; Badoual C
    Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):89-92. PubMed ID: 20336918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imported mycosis: a review of paracoccidioidomycosis].
    Bousquet A; Dussart C; Drouillard I; Charbel EC; Boiron P
    Med Mal Infect; 2007 Dec; 37 Suppl 3():S210-4. PubMed ID: 17988812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual Otolaryngologic Manifestations of Paracoccidioidomycosis: A Case Report and Review of Literature.
    Lucinda LR; Polanski JF
    Am J Trop Med Hyg; 2017 May; 96(5):1136-1138. PubMed ID: 28500805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary Paracoccidioidomycosis: An Unusual Infection Simulating Malignant Neoplasm.
    Steinbrück K; Fernandes R
    Ann Hepatol; 2019; 18(1):258-262. PubMed ID: 31113602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.